Advanced search
Publication Cover
Hematology Volume 7, 2002 - Issue 3
Submit an article Journal homepage
104
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Troxacitabine Activity in Extramedullary Myeloid Leukemia

Yesid Alvarado
,
Hagop M. Kantarjian
,
Jorge E. Cortes
,
Efrosynl Apostolidou
,
Carol Bivins
&
Francis J. Giles
Pages 179-185 | Published online: 04 Sep 2013

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

R. Swords & F. Giles. (2007) Troxacitabine in acute leukemia. Hematology 12:3, pages 219-227.
Read now
Ronan Swords, Effrosyni Apostolidou & Francis Giles. (2006) Troxacitabine in leukemia. Hematology 11:5-6, pages 321-329.
Read now

Articles from other publishers (4)

Gail J. Roboz, Francis J. Giles, Ellen K. Ritchie, Sandra Allen-Bard, Tania J. Curcio, Meredith A. Wilkes, S. Lani Park, Hagop M. Kantarjian, Stefan Faderl, Farhad Ravandi, Michael J. Kelner & Eric J. Feldman. (2007) Phase I/II Study of Continuous-Infusion Troxacitabine in Refractory Acute Myeloid Leukemia. Journal of Clinical Oncology 25:1, pages 10-15.
Crossref
Nada Orsolic, Francis J. Giles, Henriette Gourdeau, Mirna Golemovic, Miloslav Beran, Jorge Cortes, Emil J Freireich, Hagop Kantarjian & Srdan Verstovsek. (2004) Troxacitabine and imatinib mesylate combination therapy of chronic myeloid leukaemia: preclinical evaluation. British Journal of Haematology 124:6, pages 727-738.
Crossref
Francis J. Giles, Eric J. Feldman, Gail J. Roboz, Richard A. Larson, Steven W. Mamus, Jorge E. Cortes, Srdan Verstovsek, Stefan Faderl, Moshe Talpaz, Miloslav Beran, Maher Albitar, Susan M. O’Brien & Hagop M. Kantarjian. (2003) Phase II study of troxacitabine, a novel dioxolane nucleoside analog, in patients with untreated or imatinib mesylate-resistant chronic myelogenous leukemia in blastic phase. Leukemia Research 27:12, pages 1091-1096.
Crossref
Francis J. GilesHagop M. KantarjianJorge E. CortesGuillermo Garcia-ManeroSrdan VerstovsekStefan FaderlDeborah A. ThomasAlessandra FerrajoliSusan O’BrienJay K. WathenLian-Chun XiaoDonald A. BerryElihu H. Estey. (2003) Adaptive Randomized Study of Idarubicin and Cytarabine Versus Troxacitabine and Cytarabine Versus Troxacitabine and Idarubicin in Untreated Patients 50 Years or Older With Adverse Karyotype Acute Myeloid Leukemia. Journal of Clinical Oncology 21:9, pages 1722-1727.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.